Market structure — ambulatory EHR
The market is fragmented — and that's the opening
The US ambulatory EHR market has no dominant owner of the small independent practice. The top 3 hold ~40%; a long tail of 30+ smaller vendors splits ~38%. Against that backdrop, REV's plan of ~866 providers in five years is ~0.3% of US PCPs — a switching target, not a share-grab.
~866 providers in 5 years is ~0.3% of the market — viable, not heroic.
Epic's ~20% is concentrated in large groups and health systems, not the 1–5 clinician practice REV serves.
The addressable pool is the ~106,000 PCPs sitting on the fragmented long tail of 30+ small/legacy vendors —
REV's plan is ~1% of that. And the 2026–27 FHIR mandates give those long-tail practices a
concrete reason to switch (see Why now).
Why this is REV's opening
- Top 3 (Epic, eClinicalWorks, athenahealth) ≈ 38%; everything else is a long tail.
- ~38% sits in 30+ smaller vendors — none individually dominant.
- Epic's ~20% is concentrated in large groups & health systems, not the 1–5 clinician practice.
- The <5-physician segment is ~36% of the market (Grand View, 2024) and the most underserved — REV's wedge.
- REV's 866 providers is ~0.3% of US PCPs / ~1% of the long tail — achievable on a single $4M seed.
Sources & notes
- Ambulatory EHR market share (top 10): Definitive Healthcare (DHC Visuals), Oct 2025. Ranks 11+ are REV estimates — Definitive publishes only the top 10, so we allocated the ~37.8% residual across the known long-tail vendors by rough size (directional, not sourced per vendor).
- <5-physician segment share: Grand View Research, US ambulatory EHR, 2024.
- US PCP base ~280,000 (AAMC/HRSA) — see market size. Est. PCPs = vendor ambulatory share × 280,000; it assumes PCPs distribute like the overall ambulatory market, so it overstates specialty-focused vendors († ModMed, Nextech) and likely understates primary-care-leaning ones.
- Shares vary by source/definition (installed base vs revenue vs new sales) — directional. REV is pre-launch and not on the chart.